[
  {
    "ts": "2026-02-04T03:10:31+00:00",
    "headline": "Bristol-Myers Squibb Earnings: What To Look For From BMY",
    "summary": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results this Thursday before the bell. Here’s what to expect.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-earnings-look-031031245.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "963eef58-cf2e-37e4-93a4-602e6b53b0f6",
      "content": {
        "id": "963eef58-cf2e-37e4-93a4-602e6b53b0f6",
        "contentType": "STORY",
        "title": "Bristol-Myers Squibb Earnings: What To Look For From BMY",
        "description": "",
        "summary": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results this Thursday before the bell. Here’s what to expect.",
        "pubDate": "2026-02-04T03:10:31Z",
        "displayTime": "2026-02-04T03:10:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "BMY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gk.7_kJOBQAPS7VxEfLOgw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YM1F85oh4xO4w1Qalh6PGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-earnings-look-031031245.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-earnings-look-031031245.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T12:00:00+00:00",
    "headline": "OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb",
    "summary": "OXB to become commercial manufacturer of lentiviral vectors for Bristol Myers Squibb (BMS) CAR-T programmesMulti-year agreement with five-year initial term and option to extend Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has expanded its strategic partnership with Bristol Myers Squibb (“BMS”) (NYSE: BMY), signing a new Commercial Supply Agreement (CSA) for the manufacture and supply of lentiviral vectors for BMS",
    "url": "https://finance.yahoo.com/news/oxb-signs-multi-commercial-supply-120000543.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "b9de7b90-a179-3d38-92f8-0740022f5083",
      "content": {
        "id": "b9de7b90-a179-3d38-92f8-0740022f5083",
        "contentType": "STORY",
        "title": "OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb",
        "description": "",
        "summary": "OXB to become commercial manufacturer of lentiviral vectors for Bristol Myers Squibb (BMS) CAR-T programmesMulti-year agreement with five-year initial term and option to extend Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has expanded its strategic partnership with Bristol Myers Squibb (“BMS”) (NYSE: BMY), signing a new Commercial Supply Agreement (CSA) for the manufacture and supply of lentiviral vectors for BMS",
        "pubDate": "2026-02-04T12:00:00Z",
        "displayTime": "2026-02-04T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/bfca081f91ad81679e84477c36835a1f",
          "originalWidth": 546,
          "originalHeight": 248,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8f7JS1jMZuzp03fo7ES8aQ--~B/aD0yNDg7dz01NDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bfca081f91ad81679e84477c36835a1f.cf.webp",
              "width": 546,
              "height": 248,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LqOh5.4K5HSPs4ukk.y8pA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bfca081f91ad81679e84477c36835a1f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/oxb-signs-multi-commercial-supply-120000543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/oxb-signs-multi-commercial-supply-120000543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T11:59:00+00:00",
    "headline": "Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi",
    "summary": "PRINCETON, N.J., February 04, 2026--Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-teams-kasey-115900483.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "3500d246-37e9-3706-8805-366f1ba8f208",
      "content": {
        "id": "3500d246-37e9-3706-8805-366f1ba8f208",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi",
        "description": "",
        "summary": "PRINCETON, N.J., February 04, 2026--Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi",
        "pubDate": "2026-02-04T11:59:00Z",
        "displayTime": "2026-02-04T11:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/ef8000bec1f8c22f50a3596ada663de0",
          "originalWidth": 480,
          "originalHeight": 320,
          "caption": "Kasey Keller Photo: Axel Alarcon and Alan Alarcon",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LWNtCuQTtPUWPrk44_9AdQ--~B/aD0zMjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ef8000bec1f8c22f50a3596ada663de0.cf.webp",
              "width": 480,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tELx6PhJ.142dvFdbCC2sw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ef8000bec1f8c22f50a3596ada663de0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-teams-kasey-115900483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-teams-kasey-115900483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T12:05:02+00:00",
    "headline": "GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates",
    "summary": "Glaxo (GSK) delivered earnings and revenue surprises of +6.25% and +2.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/gsk-gsk-surpasses-q4-earnings-120502013.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c7a767b6-7519-35e9-a5fa-471bb452b8aa",
      "content": {
        "id": "c7a767b6-7519-35e9-a5fa-471bb452b8aa",
        "contentType": "STORY",
        "title": "GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates",
        "description": "",
        "summary": "Glaxo (GSK) delivered earnings and revenue surprises of +6.25% and +2.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2026-02-04T12:05:02Z",
        "displayTime": "2026-02-04T12:05:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94",
          "originalWidth": 900,
          "originalHeight": 588,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5gRNxwBpnI6i3Dv1dI7wfg--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94.cf.webp",
              "width": 900,
              "height": 588,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3D4iv84vYyo09.dnUK_wsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gsk-gsk-surpasses-q4-earnings-120502013.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gsk-gsk-surpasses-q4-earnings-120502013.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]